The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rizatriptan Benzoate tablets in eight distinct configurations. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year option periods. It will establish a national supply source for the listed items for purchase by several federal agencies through prime vendor programs. The current projected solicitation date is June 2022, though the DLA reserves the right to issue it before or after that date. The solicitation will be unrestricted, fully competitive, and posted to the DLA Bid Board System and Sam.gov.